Very Soon, Thousands Of Individual Banknotes Of U.S. Paper Currency Could Say ‘Donald J. Trump Protects Pedophiles’
In Trump's America, customized rubber stamps are cheap and plentiful.
In Trump's America, customized rubber stamps are cheap and plentiful.
As federal borrowing caps tighten financing options for law students, one organization is stepping in to negotiate the terms they can't secure alone.
As federal borrowing caps tighten financing options for law students, one organization is stepping in to negotiate the terms they can't secure alone.
Enforce the law? In this economy?
An NYU Stern report links private equity in healthcare to worse outcomes and higher bankruptcy risk, calling for reforms and stronger oversight.
Our president is wasting billions he doesn’t have to fight a war he didn’t have to fight.
And that's just for THIS month.
Designed to reduce manual docket work by prioritizing what litigators need most: on-demand full docket summarization that explains the whole case to date, followed by on-demand document summaries for filing triage, and AI-powered natural language searching for faster search and retrieval.
Trump responds to only one thing: the market.
Experts say Hims & Hers’ acquisition of Eucalyptus positions the company for global expansion and revenue diversification amid U.S. GLP-1 regulatory challenges.
Let's cut through the confusion and focus on what actually matters for your planning.
The new generation of AI-related legal issues are inherently cross-disciplinary, implicating corporate law, intellectual property, data privacy, employment, corporate governance and regulatory compliance.
Digital health is entering a more mature phase in 2026 as consolidation accelerates through targeted M&A, driven by the need for scale, artificial intelligence and pressure from payers, investors say.
Saint Laurent, Miu Miu, and Cos maintained their top-three positions as fashion's hottest brands for another quarter.
Across all industries, the total number of companies on track to go public could make this week the most active for IPOs since 2021. Despite the partial government shutdown, there are paths biotechs can pursue to the public markets.
As shakedowns go, it's pretty shakey.
Old associations are resurfacing, raising uncomfortable questions for Wall Street's most powerful bank.